Author

Rob Glynne-Jones 1

1 Mount Vernon Cancer Centre Dept. of Oncology - Oncology, Mount Vernon Cancer Centre Dept. of Oncology; Northwood/GB

Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Rob Glynne-Jones, Per J. Nilsson, C. Aschele, Vicky Goh, D. Pfeiffert, Andres Cervantes, Dirk Arnold

Colorectal cancer: Adjuvant treatment - according to molecular subtyping, immunoscore or simply TNM staging?

Rob Glynne-Jones

Colorectal cancer: Adjuvant treatment - according to molecular subtyping, immunoscore or simply TNM staging?

Rob Glynne-Jones

Early rectal cancer: Guidelines

Rob Glynne-Jones

FROM SURGERY TO THE DELIVERY OF ADJUVANT THERAPIES IN STAGE III COLORECTAL CANCER PATIENTS: THE ROLE PRE-OPERATIVE NEUTROPHIL TO LYMPHOCYTE RATIO.

Marco Giacometti, Robin H. Kennedy, Rob Glynne-Jones, Nikola Anyamene, Omer Aziz, John T. Jenkins

Panel discussion

Rob Glynne-Jones

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Rob Glynne-Jones, Lucjan Wyrwicz, Gina Brown, Claus Rödel, Andres Cervantes, Dirk Arnold

Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Jeanin E. van Hooft, Emo E. van Halsema, Geoffroy Vanbiervliet, Regina G.H. Beets-Tan, John DeWitt, Fergal Donnellan, Jean-Marc Dumonceau, Rob Glynne-Jones, Cesare Hassan, Javier Jiménez Pérez, Soren Meisner, V. Raman Muthusamy, Michael C. Parker, Jean-Marc Regimbeau, Charles Sabbagh, Jayesh Sagar, Pieter J. Tanis, Jo Vand

The use of neo-adjuvant treatments to downstage advanced colorectal tumours

Rob Glynne-Jones

The use of neo-adjuvant treatments to downstage advanced colorectal tumours

Rob Glynne-Jones

Item 1 - 10 / 11
1
2